Skip to content
Study details
Enrolling now

Comparison of Interscalene Catheter to Single Injection Interscalene Blocks for Total Shoulder Arthroplasties

Melinda Seering
NCT IDNCT05868330ClinicalTrials.gov data as of Apr 2026
Phase

Phase 4

Target enrollment

56

Study length

about 2.5 years

Ages

18–90

Locations

1 site in IA

About this study

This trial is testing whether using an interscalene catheter with a continuous infusion provides better pain relief than a single injection nerve block after total shoulder surgery. The goal is to reduce the need for opioid medications post-surgery and improve patient satisfaction.

Based on ClinicalTrials.gov records.

What participants do

  • 1.Undergo Exparel Single Shot Interscalene Block
  • 2.Undergo Interscalene Catheter
PhasePhase 4
Primary goalPain Score Assessed by functional pain score at POD 1

Participation effort

Estimated from trial records. Details can vary by site.

Time + visits
Low10%
Logistics
Moderate50%

Logistics difficulty varies by site location and availability.

Trial highlights

Treatment details

Auto-extracted from trial records to preview treatments and outcomes.

Endpoints

Primary: Pain Score Assessed by functional pain score at POD 1

Secondary: Measurement of the narcotics used to control pain (PACU), Measurement of the narcotics used to control pain (POD 1), Measurement of the narcotics used to control pain (POD 30), Measurement of the narcotics used to control pain (POD 7), Measurement of the narcotics used to control pain (POD 90), Pain Scores Assessed by functional pain scores on Post-operative day 30, Pain Scores Assessed by functional pain scores on Post-operative day 7, Pain Scores Assessed by functional pain scores on Post-operative day 90

Devices

therapeutic